Treatment by Posaconazole Tablets, Compared to Posaconazole Suspension, Does Not Reduce Variability of Posaconazole Trough Concentrations

Elodie Gautier‐Veyret, Léa Bolcato, Matthieu Roustit, Stephanie J. Weiss, Julia Tonini, Marie‐Pierre Brenier‐Pinchart, Muriel Cornet, Anne Thiebaut‐Bertrand, Françoise Stanke‐Labesque

Antimicrobial Agents and Chemotherapy · 2019 · 23 citations · 27 references

DOIFull text

Open access

Concepts

Abstract

The delayed-release tablet formulation of posaconazole (POS-tab) results in higher plasma POS trough concentrations (C min ) than the oral suspension (POS-susp), which raises the question of the utility of therapeutic drug monitoring (TDM). We aimed to compare the variability of the POS C min for the two formulations and identify determinants of the POS-tab C min and its variability.

References

27